Skip to main content
Log in

Early combination treatment with intratympanic steroid injection in severe to profound sudden sensorineural hearing loss improves speech discrimination performance

  • Otology
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

The objective of the study was to determine the therapeutic efficacy of early combined treatment with intratympanic steroid injection (ITSI) in patients with severe to profound sudden sensorineural hearing loss (SSNHL), who did not respond to initial systemic steroid treatment (SST). The study design included historical controlled trials (retrospective analysis for the SST group). Patients (n = 73; 38 women and 35 men) diagnosed with severe to profound SSNHL at the time of their first visit in tertiary referral centers were recruited. Among these 73 patients, 30 patients who showed no early response within a week after the start of initial SST were prospectively included as the ITSI group. ITSI was performed twice a week for two consecutive weeks. In contrast, 43 patients with the same condition who did not receive ITSI were retrospectively included as the SST group. For each group, pure-tone audiogram (PTA) and speech discrimination score (SDS) tests were performed before SST and more than 2 months after termination of treatment in each group. After termination of each treatment, the final average gain on PTA showed no significant difference between the two groups; however, the final average gain of SDS demonstrated a significantly better recovery in the ITSI group. ITSI as part of an early combined therapy represents an effective treatment in terms of the improvement of SDS in severe to profound SSNHL showing no early response to initial SST.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Hamid M, Trune D (2008) Issues, indications, and controversies regarding intratympanic steroid perfusion. Curr Opin Otolaryngol Head Neck Surg 16:434–440

    Article  PubMed  Google Scholar 

  2. Mattox DE, Simmons FB (1977) Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol 86:463–480

    PubMed  CAS  Google Scholar 

  3. Wilson WR, Byl FM, Laird N (1980) The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study. Arch Otolaryngol 106:772–776

    Article  PubMed  CAS  Google Scholar 

  4. Jones N, Ludman H (1998) Acquired sensorineural hearing loss. In: Ludman H, Wright T (eds) Diseases of the ear, 6th edn. Arnold, London, pp 495–497

    Google Scholar 

  5. Ito S, Fuse T, Yokota M et al (2002) Prognosis is predicted by early hearing improvement in patients with idiopathic sudden sensorineural hearing loss. Clin Otolaryngol 27:501–504

    Article  PubMed  CAS  Google Scholar 

  6. Rauch SD (2004) Intratympanic steroids for sensorineural hearing loss. Otolaryngol Clin North Am 37:1061–1074

    Article  PubMed  Google Scholar 

  7. Cvorovic L, Deric D, Probst R, Hegemann S (2008) Prognostic model for predicting hearing recovery in idiopathic sudden sensorineural hearing loss. Otol Neurotol 29:464–469

    Article  PubMed  Google Scholar 

  8. Schreiber BE, Agrup C, Haskard DO, Luxon LM (2010) Sudden sensorineural hearing loss. Lancet 375(9721):1203–1211

    Article  PubMed  Google Scholar 

  9. Moon IS, Kim J, Lee SY, Choi HS, Lee WS (2009) How long should the sudden hearing loss patients be followed after early steroid combination therapy? Eur Arch Otorhinolaryngol 266(9):1391–1395

    Article  PubMed  Google Scholar 

  10. Siegel LG (1975) The treatment of idiopathic sudden sensorineural hearing loss. Otolaryngol Clin North Am 8:467–473

    PubMed  CAS  Google Scholar 

  11. Silverstein H, Choo D, Rosenberg SI, Kuhn J, Seidman M, Stein I (1996) Intratympanic steroid treatment of inner ear disease and tinnitus (preliminary report). Ear Nose Throat J 75:468–471

    PubMed  CAS  Google Scholar 

  12. Parnes LS, Sun AH, Freeman DJ (1999) Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 109:1–17

    Article  PubMed  CAS  Google Scholar 

  13. Banerjee A, Parnes LS (2005) Intratympanic corticosteroids for sudden idiopathic sensorineural hearing loss. Otol Neurotol 26:878–881

    Article  PubMed  Google Scholar 

  14. Battaglia A, Burchette R, Cueva R (2008) Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss. Otol Neurotol 29:453–460

    Article  PubMed  Google Scholar 

  15. Hong SM, Park CH, Lee JH (2009) Hearing outcomes of daily intratympanic dexamethasone alone as a primary treatment modality for ISSHL. Otolaryngol Head Neck Surg 141:579–583

    Article  PubMed  Google Scholar 

  16. Lauterman J, Sudhoff H, Junker R (2005) Transtympanic corticoid therapy for acute profound loss. Eur Arch Otorhinolaryngol 262:587–591

    Article  Google Scholar 

  17. Battista RA (2005) Intratympanic dexamethasone for profound idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 132:902–905

    Article  PubMed  Google Scholar 

  18. Chen CY, Halpin C, Rauch SD (2003) Oral steroid treatment of sudden sensorineural hearing loss: a ten year retrospective analysis. Otol Neurotol 24:728–733

    Article  PubMed  Google Scholar 

  19. Cinamon U, Bendet E, Kronenberg J (2001) Steroids, carbogen or placebo for sudden hearing loss: a prospective double-blind study. Eur Arch Otorhinolaryngol 258:477–480

    Article  PubMed  CAS  Google Scholar 

  20. Guan-Min H, Hung-Ching L, Min-Tsan S et al (2004) Effectiveness of intratympanic dexamethasone injection in sudden deafness patients as salvage treatment. Laryngoscope 114:1184–1189

    Article  Google Scholar 

  21. Herr BD, Marzo SJ (2005) Intratympanic steroid perfusion for refractory sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 132:527–531

    Article  PubMed  Google Scholar 

  22. Slattery WH, Fisher LM, Iqbal Z, Friedman RA, Liu N (2005) Intratympanic steroid for the treatment of sudden hearing loss. Otolaryngol Head Neck Surg 133:251–259

    Article  PubMed  Google Scholar 

  23. Choung YH, Park K, Shin YR, Cho MJ (2006) Intratympanic dexamethasone injection for refractory sudden sensorineural hearing loss. Laryngoscope 116:747–752

    Article  PubMed  CAS  Google Scholar 

  24. Xenellis J, Papadimitriou N, Nikolopoulos T et al (2006) Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study. Otolaryngol Head Neck Surg 134:940–945

    Article  PubMed  Google Scholar 

  25. Haynes DS, O’Malley M, Cohen S et al (2007) Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Laryngoscope 117:3–15

    Article  PubMed  CAS  Google Scholar 

  26. Plaza G, Herraiz C (2007) Intratympanic steroids for treatment of sudden hearing loss after failure of intravenous therapy. Otolaryngol Head Neck Surg 137:74–78

    Article  PubMed  Google Scholar 

  27. Ahn JH, Han MW, Kim JH, Chung JW, Yoon TH (2008) Therapeutic effectiveness over time of intratympanic dexamethasone as salvage treatment of sudden deafness. Acta Otolaryngol 128(2):128–131

    Article  PubMed  CAS  Google Scholar 

  28. Plontke SK, Plinkert PK, Plinkert B, Koitschev A, Zenner HP, Löwenheim H (2002) Transtympanic endoscopy for drug delivery to the inner ear using a new microendoscope. Adv Otorhinolaryngol 59:149–155

    PubMed  Google Scholar 

  29. Arnold W, Senn P, Hennig M et al (2005) Novel slow- and fast-type drug release round-window microimplants for local drug application to the cochlea: an experimental study in guinea pigs. Audiol Neurootol 10(1):53–63

    Article  PubMed  CAS  Google Scholar 

  30. Paulson DP, Abuzeid W, Jiang H, Oe T, O’Malley BW, Li D (2008) A novel controlled local drug delivery system for inner ear disease. Laryngoscope 118(4):706–711

    Article  PubMed  CAS  Google Scholar 

  31. Horie RT, Sakamoto T, Nakagawa T et al (2010) Sustained delivery of lidocaine into the cochlea using poly lactic/glycolic acid microparticles. Laryngoscope 120(2):377–383

    PubMed  CAS  Google Scholar 

  32. Alzamil KS, Linthicum FH Jr (2000) Extraneous round window membranes and plugs: possible effect on intratympanic therapy. Ann Otol Rhinol Laryngol 109(1):30–32

    PubMed  CAS  Google Scholar 

  33. Plontke SK (2011) Evaluation of the round window niche before local drug delivery to the inner ear using a new mini-otoscope. Otol Neurotol 32(1):183–185

    Article  PubMed  Google Scholar 

  34. Borden RC, Saunders JE, Berryhill WE, Krempl GA, Thompson DM, Queimado L (2011) Hyaluronic acid hydrogel sustains the delivery of dexamethasone across the round window membrane. Audiol Neurootol 16(1):1–11

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by a clinical research grant provided by the Seoul National University Boramae Medical Center.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Young Ho Kim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, Y.H., Park, K.T., Choi, B.Y. et al. Early combination treatment with intratympanic steroid injection in severe to profound sudden sensorineural hearing loss improves speech discrimination performance. Eur Arch Otorhinolaryngol 269, 2173–2178 (2012). https://doi.org/10.1007/s00405-011-1874-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-011-1874-6

Keywords

Navigation